Kewaunee Scientific Corporation (KEQU)
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.
Investigation
08/13/2021
Initial Lawsuit
09/15/2021
Lawsuit Progression
01/26/2022
Investigation regarding The Honest Company’s statements made in connection with its initial public offering (IPO), pre-IPO growth, global Covid-19 pandemic impact on sales and inventory and subsequent financial projections.
08/13/2021
The Honest Company discloses its Q2 2021 financial results, showing revenue growth of 3% from the second quarter of 2020: “excluding an estimated $3.7 million COVID-19 stock-up impact primarily in Diapers and Wipes in the prior year period, revenue growth was 9%.”
Stock Impact
Close | Previous close | Price variation | Percentage variation |
---|---|---|---|
$10.07 | $14.05 | $-3.98 | -28.33% |
Plaintiff brings this securities class action on behalf of persons and entities that purchased or otherwise acquired The Honest Company common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the company’s May 2021 initial public offering (IPO).
According to the complaint, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, defendants allegedly failed to disclose to investors:
(1) that, prior to the IPO, the company’s results had been significantly
impacted by a multimillion-dollar COVID-19 stock-up for products in the Diapers and Wipes category and Household and Wellness category;
(2) that, at the time of the IPO, the company was experiencing decelerating demand for such products;
(3) that, as a result, the company’s financial results would likely be adversely impacted; and
(4) that, as a result of the foregoing, defendants’ positive statements about the company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
01/26/2022
The court issued an order appointing the lead plaintiff and lead counsel.
02/21/2022
This federal securities class action is brought on behalf of all persons or entities who purchased or otherwise acquired Honest common stock pursuant and/or traceable to the Offering Documents issued in connection with the initial public offering (IPO), commenced on or about May 4, 2021, of 29,678,050 shares of common stock at a price of $16.00 per share.
Operative complaint
03/14/2022
A motion to dismiss was filed with the court.
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Amicus Therapeutics, Inc. (FOLD) breached their fiduciary duties to the company and its shareholders.
Confidential investigation: officers & directors’ potential breach of fiduciary duties to investors.
Whether directors and officers of Payoneer Global Inc. (PAYO) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of LegalZoom.com, Inc. (LZ) breached their fiduciary duties to the company and its shareholders.